Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2015

Open Access 01-12-2015 | Case report

Coexistence of Graves’ disease and unilateral functioning Struma ovarii: a case report

Authors: Tullaya Sitasuwan, Suchanan Hanamornroongruang, Thavatchai Peerapatdit, Nuntakorn Thongtang

Published in: BMC Endocrine Disorders | Issue 1/2015

Login to get access

Abstract

Background

Coexisting of Graves’ disease and functioning struma ovarii is a rare condition. Although the histology of struma ovarii predominantly composed of thyrocytes, the majority of the patients did not have thyrotoxicosis. The mechanism underlying the functioning status of the tumor is still unclear but the presence of thyroid stimulating hormone receptor (TSHR) is thought to play a role. Here we describe the patient presentation and report the TSHR expression of the tumor.

Case presentation

A 56-year old Asian woman presented with long standing thyrotoxicosis for 23 years. She was diagnosed with Graves’ disease and thyroid nodules. She had bilateral exophthalmos and had high titer of plasma TSHR antibody. Total thyroidectomy was performed and the histologic findings confirmed the clinical diagnosis. The patient had persistent thyrotoxicosis postoperatively. Thyroid uptake demonstrated the adequacy of the thyroid surgery and the whole body scan confirmed the presence of functioning thyroid tissue at pelvic area. The surgery was scheduled and the patient had hypothyroidism after the surgery. The pathological diagnosis was struma ovarii at right ovary. We performed TSHR staining in both the patient’s struma ovarii and in 3 cases of non-functioning struma ovarii. The staining results were all positive and the intensity of the TSHR staining of functioning struma ovarii was the same as that in other cases of non-functioning tumors, suggesting that the determinant of functioning struma ovarii might be the presence of TSHR stimuli rather than the intensity of the TSHR in the ovarian tissue.

Conclusion

In patients with Graves’ disease with persistent or recurrent thyrotoxicosis after adequate ablative treatment, the possibility of ectopic thyroid hormone production should be considered. TSHR expression is found in patients with functioning and non-functioning struma ovarii and cannot solely be used to determine the functioning status of the tumor.
Literature
1.
go back to reference Bayot MR, Chopra IJ. Coexistence of struma ovarii and Graves’ disease. Thyroid. 1995;5(6):469–71.CrossRefPubMed Bayot MR, Chopra IJ. Coexistence of struma ovarii and Graves’ disease. Thyroid. 1995;5(6):469–71.CrossRefPubMed
3.
go back to reference Anastasilakis AD, Ruggeri RM, Polyzos SA, Makras P, Molyva D, Campenni A, et al. Coexistence of Graves’ disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature. Metabolism. 2013;62(10):1350–6. doi:10.1016/j.metabol.2013.05.013.CrossRefPubMed Anastasilakis AD, Ruggeri RM, Polyzos SA, Makras P, Molyva D, Campenni A, et al. Coexistence of Graves’ disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature. Metabolism. 2013;62(10):1350–6. doi:10.​1016/​j.​metabol.​2013.​05.​013.CrossRefPubMed
4.
go back to reference Teale E, Gouldesbrough DR, Peacey SR. Graves’ disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyrotropin receptor stimulating antibodies. Thyroid. 2006;16(8):791–3. doi:10.1089/thy.2006.16.791.CrossRefPubMed Teale E, Gouldesbrough DR, Peacey SR. Graves’ disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyrotropin receptor stimulating antibodies. Thyroid. 2006;16(8):791–3. doi:10.​1089/​thy.​2006.​16.​791.CrossRefPubMed
5.
go back to reference Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol. 1993;12(4):333–43.CrossRefPubMed Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol. 1993;12(4):333–43.CrossRefPubMed
6.
go back to reference Mimura Y, Kishida M, Masuyama H, Suwaki N, Kodama J, Otsuka F, et al. Coexistence of Graves’ disease and struma ovarii: case report and literature review. Endocr J. 2001;48(2):255–60.CrossRefPubMed Mimura Y, Kishida M, Masuyama H, Suwaki N, Kodama J, Otsuka F, et al. Coexistence of Graves’ disease and struma ovarii: case report and literature review. Endocr J. 2001;48(2):255–60.CrossRefPubMed
7.
go back to reference Kempers RD, Dockerty MB, Hoffman DL, Bartholomew LG. Struma ovarii--ascitic, hyperthyroid, and asymptomatic syndromes. Ann Intern Med. 1970;72(6):883–93.CrossRefPubMed Kempers RD, Dockerty MB, Hoffman DL, Bartholomew LG. Struma ovarii--ascitic, hyperthyroid, and asymptomatic syndromes. Ann Intern Med. 1970;72(6):883–93.CrossRefPubMed
9.
go back to reference Lefort G, Commenges-Ducos M, Denechaud M, Rivel J, Latapie JL. Ovarian goiter in Basedow’s disease. Role of thyroid-stimulating immunoglobulins? Nouv Presse Med. 1981;10(26):2209–10.PubMed Lefort G, Commenges-Ducos M, Denechaud M, Rivel J, Latapie JL. Ovarian goiter in Basedow’s disease. Role of thyroid-stimulating immunoglobulins? Nouv Presse Med. 1981;10(26):2209–10.PubMed
10.
go back to reference Kung AW, Ma JT, Wang C, Young RT. Hyperthyroidism during pregnancy due to coexistence of struma ovarii and Graves’ disease. Postgrad Med J. 1990;66(772):132–3.PubMedCentralCrossRefPubMed Kung AW, Ma JT, Wang C, Young RT. Hyperthyroidism during pregnancy due to coexistence of struma ovarii and Graves’ disease. Postgrad Med J. 1990;66(772):132–3.PubMedCentralCrossRefPubMed
11.
go back to reference Guida M, Mandato VD, Di Spiezio SA, Di Carlo C, Giordano E, Nappi C. Coexistence of Graves’ disease and benign struma ovarii in a patient with marked ascites and elevated CA-125 levels. J Endocrinol Invest. 2005;28(9):827–30.CrossRefPubMed Guida M, Mandato VD, Di Spiezio SA, Di Carlo C, Giordano E, Nappi C. Coexistence of Graves’ disease and benign struma ovarii in a patient with marked ascites and elevated CA-125 levels. J Endocrinol Invest. 2005;28(9):827–30.CrossRefPubMed
13.
go back to reference Joja I, Asakawa T, Mitsumori A, Nakagawa T, Akaki S, Yamamoto M, et al. I-123 uptake in nonfunctional struma ovarii. Clin Nucl Med. 1998;23(1):10–2.CrossRefPubMed Joja I, Asakawa T, Mitsumori A, Nakagawa T, Akaki S, Yamamoto M, et al. I-123 uptake in nonfunctional struma ovarii. Clin Nucl Med. 1998;23(1):10–2.CrossRefPubMed
14.
go back to reference Nodine JH, Maldia G. Pseudostruma ovarii. Obstet Gynecol. 1961;17:460–3.PubMed Nodine JH, Maldia G. Pseudostruma ovarii. Obstet Gynecol. 1961;17:460–3.PubMed
15.
go back to reference Lazarus JH, Richards AR, MacPherson MJ, Dinnen JS, Williams ED, Owen GM, et al. Struma ovarii: a case report. Clin Endocrinol (Oxf). 1987;27(6):715–20.CrossRef Lazarus JH, Richards AR, MacPherson MJ, Dinnen JS, Williams ED, Owen GM, et al. Struma ovarii: a case report. Clin Endocrinol (Oxf). 1987;27(6):715–20.CrossRef
16.
Metadata
Title
Coexistence of Graves’ disease and unilateral functioning Struma ovarii: a case report
Authors
Tullaya Sitasuwan
Suchanan Hanamornroongruang
Thavatchai Peerapatdit
Nuntakorn Thongtang
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2015
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-015-0060-z

Other articles of this Issue 1/2015

BMC Endocrine Disorders 1/2015 Go to the issue